Alcohol consumption in relation to cognitive dysfunction and dementia: A systematic review and dose-response meta-analysis of prospective cohort studies.

Alcohol Dementia Subjective cognitive dysfunction

Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
20 Jul 2024
Historique:
received: 26 04 2024
revised: 13 07 2024
accepted: 14 07 2024
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 22 7 2024
Statut: aheadofprint

Résumé

Alcohol use is associated with a wide spectrum of neurological disorders, including cognitive dysfunction and dementia. Likewise, the high prevalence of cognitive dysfunction and dementia specifies the urgent need to identify modifiable risk factors. Because findings on alcohol and cognitive dysfunction and dementia have been inconsistent, the present dose-response meta-analysis of prospective cohort studies was conducted to evaluate the available evidence. A systematic search was conducted on PubMed/MEDLINE, Scopus, Embase, and PsychInfo databases and Google Scholar up to April, 2023. In the dose-response meta-analysis, a restricted cubic spline regression model was conducted to evaluate a possible non-linear relation between alcohol intake and the outcomes. Random-effects model was used to perform the meta-analysis and evaluate heterogeneity. Egger's test and a funnel plot were used to assess small study effects. Subgroup analyses were carried out to explore possible sources of heterogeneity. Seventeen eligible studies comprising 80,680 total persons with 4,929 cases for dementia and 13,530 total persons with 1579 cases for cognitive dysfunction were included for dose-response analysis. When compared to the reference group of 0g/day of alcohol intake, the dose-response meta-analysis revealed a significant non-linear (J-shaped) association between alcohol intake and the risk of each of cognitive dysfunction, (lower dose range: 1-30.5g/day, RR: 0.97; 95% CI 0.95-0.99; higher dose range: >30.5g/day, RR: 1.07; 95% CI 1.01-1.15) and dementia (lower dose range: 1-17.5g/day, RR: 0.92; 95% CI 0.88-0.96, higher dose range: >17.5g/day, RR: 1.23; 95% CI 1.09-1.35). The lowest risk was achieved at approximately 30g/day of alcohol for cognitive dysfunction and 15g/day for dementia. The J-shape association remained with subgroups defined by age (≤65; >65 years) or study duration (<10; ≥10 years) for dementia, and within age >65 and duration <10 years for cognitive dysfunction. We observed a J-shape association between alcohol consumption and both cognitive dysfunction and dementia, with light-to-moderate alcohol intake being associated with a reduced risk in adults. Further studies are needed to clarify more specifically the association between alcohol consumption and six domains of cognitive dysfunction based on diagnostic and statistical manual of mental disorders (DSM) criteria.

Sections du résumé

BACKGROUND BACKGROUND
Alcohol use is associated with a wide spectrum of neurological disorders, including cognitive dysfunction and dementia. Likewise, the high prevalence of cognitive dysfunction and dementia specifies the urgent need to identify modifiable risk factors. Because findings on alcohol and cognitive dysfunction and dementia have been inconsistent, the present dose-response meta-analysis of prospective cohort studies was conducted to evaluate the available evidence.
METHOD AND MATERIALS METHODS
A systematic search was conducted on PubMed/MEDLINE, Scopus, Embase, and PsychInfo databases and Google Scholar up to April, 2023. In the dose-response meta-analysis, a restricted cubic spline regression model was conducted to evaluate a possible non-linear relation between alcohol intake and the outcomes. Random-effects model was used to perform the meta-analysis and evaluate heterogeneity. Egger's test and a funnel plot were used to assess small study effects. Subgroup analyses were carried out to explore possible sources of heterogeneity.
RESULTS RESULTS
Seventeen eligible studies comprising 80,680 total persons with 4,929 cases for dementia and 13,530 total persons with 1579 cases for cognitive dysfunction were included for dose-response analysis. When compared to the reference group of 0g/day of alcohol intake, the dose-response meta-analysis revealed a significant non-linear (J-shaped) association between alcohol intake and the risk of each of cognitive dysfunction, (lower dose range: 1-30.5g/day, RR: 0.97; 95% CI 0.95-0.99; higher dose range: >30.5g/day, RR: 1.07; 95% CI 1.01-1.15) and dementia (lower dose range: 1-17.5g/day, RR: 0.92; 95% CI 0.88-0.96, higher dose range: >17.5g/day, RR: 1.23; 95% CI 1.09-1.35). The lowest risk was achieved at approximately 30g/day of alcohol for cognitive dysfunction and 15g/day for dementia. The J-shape association remained with subgroups defined by age (≤65; >65 years) or study duration (<10; ≥10 years) for dementia, and within age >65 and duration <10 years for cognitive dysfunction.
CONCLUSION CONCLUSIONS
We observed a J-shape association between alcohol consumption and both cognitive dysfunction and dementia, with light-to-moderate alcohol intake being associated with a reduced risk in adults. Further studies are needed to clarify more specifically the association between alcohol consumption and six domains of cognitive dysfunction based on diagnostic and statistical manual of mental disorders (DSM) criteria.

Identifiants

pubmed: 39038743
pii: S1568-1637(24)00237-X
doi: 10.1016/j.arr.2024.102419
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102419

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Meysam Zarezadeh (M)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Mahsa Mahmoudinezhad (M)

Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran; Department of Nutrition Science, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Amir Hossein Faghfouri (AH)

Maternal and Childhood Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran.

Niyaz Mohammadzadeh Honarvar (NM)

Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, 02115, USA.

Quentin R Regestein (QR)

Department of Psychiatry, Brigham and Women's Hospital, 1249 Boylston St., Boston, MA 02215, United States.

Stefania I Papatheodorou (SI)

Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Boston, MA, 02115, USA; Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, 02115, USA.

Rania A Mekary (RA)

School of Pharmacy, MCPHS University, Boston, MA, 02115, USA; Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, 02115, USA. Electronic address: rania.mekary@mcphs.edu.

Walter C Willett (WC)

Departments of Nutrition and Epidemiology, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, 02115, USA. Electronic address: wwillett@hsph.harvard.edu.

Classifications MeSH